Skip to content
OrganaBio logo rev color
  • Products
    • ImmunoPAC™ Cord Blood-Derived Immune Cells
    • HematoPAC™ HSCs and Cord Blood
    • LeukoPAC™ Apheresis-Derived Products
    • MesenPAC™ MSCs
  • Services
    • Overview
    • Cell Processing and Cryopreservation Services
    • cGMP Manufacturing
    • Assay Development and Analytical Testing
  • Compliance
  • Careers
  • Resources
    • News
    • In the Media
    • Events
    • Supply Brain
    • Catalogs & Brochures
  • About Us
    • Our Company
    • Team
  • Products
    • ImmunoPAC™ Cord Blood-Derived Immune Cells
    • HematoPAC™ HSCs and Cord Blood
    • LeukoPAC™ Apheresis-Derived Products
    • MesenPAC™ MSCs
  • Services
    • Overview
    • Cell Processing and Cryopreservation Services
    • cGMP Manufacturing
    • Assay Development and Analytical Testing
  • Compliance
  • Careers
  • Resources
    • News
    • In the Media
    • Events
    • Supply Brain
    • Catalogs & Brochures
  • About Us
    • Our Company
    • Team
Contact
footer logo
menu shape ham

Search Result

wynwood wall

MSC-Based Therapies for COVID-19 (October 2020 update)

At the beginning of August, we searched the clinicaltrials.gov database to learn more about the U.S.-based clinical trial landscape of mesenchymal stromal cell (MSC) based

Read More
OrganaBio was founded in 2018 with the mission to become the hub for tissue sourcing, clinical sample processing and contract manufacturing services to support cell and gene therapy developers around the globe.
Facebook-f Linkedin Instagram

Quick Links

  • Services
  • Products
  • About Us
  • Contact
  • Resources
  • Careers

Request More Information

  • Privacy Policy

©2025 OrganaBio. All rights reserved.

Biotech Website Design